Published on
May 5, 2025
FDA approves first drug to treat multiple sclerosis — Ocrevus for primary progressive MS
The U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). This is the first drug approved by the FDA for PPMS. Ocrevus is …
Source:
ABILITY Magazine
-
Neutral
